
### [MONDO:0020115](http://purl.obolibrary.org/obo/MONDO_0020115)
**Label:** secondary polycythemia

**Subclasses:** [MONDO:0016599](http://purl.obolibrary.org/obo/MONDO_0016599) (autosomal dominant secondary polycythemia), [MONDO:0012729](http://purl.obolibrary.org/obo/MONDO_0012729) (erythrocytosis, familial, 4), [MONDO:0019538](http://purl.obolibrary.org/obo/MONDO_0019538) (Gaisbock syndrome), [MONDO:0016598](http://purl.obolibrary.org/obo/MONDO_0016598) (autosomal recessive secondary polycythemia not associated with VHL gene), [MONDO:0016540](http://purl.obolibrary.org/obo/MONDO_0016540) (congenital secondary polycythemia), [MONDO:0009892](http://purl.obolibrary.org/obo/MONDO_0009892) (Chuvash polycythemia), [MONDO:0012353](http://purl.obolibrary.org/obo/MONDO_0012353) (erythrocytosis, familial, 3), [MONDO:0016541](http://purl.obolibrary.org/obo/MONDO_0016541) (acquired secondary polycythemia), 

**Corr. equiv. classes:** [Orphanet:247511](http://www.orpha.net/ORDO/Orphanet_247511), [Orphanet:238557](http://www.orpha.net/ORDO/Orphanet_238557), [Orphanet:238547](http://www.orpha.net/ORDO/Orphanet_238547), [Orphanet:238536](http://www.orpha.net/ORDO/Orphanet_238536), [OMIM:611783](http://purl.obolibrary.org/obo/OMIM_611783), [Orphanet:247378](http://www.orpha.net/ORDO/Orphanet_247378), [OMIM:609820](http://purl.obolibrary.org/obo/OMIM_609820), [OMIM:263400](http://purl.obolibrary.org/obo/OMIM_263400), [Orphanet:90041](http://www.orpha.net/ORDO/Orphanet_90041), 

**Class expressions from DL-Learner:**

- [HP:0001899](http://purl.obolibrary.org/obo/HP_0001899) (Increased hematocrit) and [HP:0001900](http://purl.obolibrary.org/obo/HP_0001900) (Increased hemoglobin) 55.40%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001899](http://purl.obolibrary.org/obo/HP_0001899) (Increased hematocrit) 55.40%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001899](http://purl.obolibrary.org/obo/HP_0001899) (Increased hematocrit) and [HP:0001900](http://purl.obolibrary.org/obo/HP_0001900) (Increased hemoglobin) 55.40%
- [HP:0001900](http://purl.obolibrary.org/obo/HP_0001900) (Increased hemoglobin) 52.02%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001900](http://purl.obolibrary.org/obo/HP_0001900) (Increased hemoglobin) 52.02%
- [HP:0001899](http://purl.obolibrary.org/obo/HP_0001899) (Increased hematocrit) 49.40%
- [HP:0001901](http://purl.obolibrary.org/obo/HP_0001901) (Polycythemia) 35.56%
- [HP:0001877](http://purl.obolibrary.org/obo/HP_0001877) (Abnormality of erythrocytes) 20.39%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 18.93%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) 17.81%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 17.55%
- Thing 17.55%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 17.55%


